Rehabilitation in Patients With Pulmonary Fibrosis

Not yet recruiting

• Conditions: Rehabilitation

• Registration Number: NCT06677047
• Lead Sponsor: Assiut University

Brief Summary

This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition

Detailed Description

program is essential for understanding its efficacy. Functional status refers to an individual's ability to perform daily activities and maintain independence, which is particularly important for patients with chronic illnesses like PF. Evaluating changes in functional status not only helps in determining the success of rehabilitation efforts but also provides insights into the overall impact of exercise on patients' quality of life.

Study Timeline

• Status Verified: 2024-10
• Study First Submitted: 2024-11-05
• Study First Submitted QC: 2024-11-05
• Last Update Submitted: 2024-11-05
• Study First Posted: 2024-11-06
• Last Update Posted: 2024-11-06
• Study Start: 2025-01-20
• Primary Completion: 2025-06-20
• Study Completion: 2025-08-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 1. **Diagnosis of Pulmonary Fibrosis:**

• Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography).

  2. **Age Range:**

• Participants should be adults aged 18 years and older to capture the adult population affected by the disease.

  3. **Stable Clinical Condition:**

• Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen

Exclusion Criteria

• 1. **Other Significant Lung Diseases:**

• Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results.

  2. **Acute Exacerbations:**

• Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment.

  3. **Severe Comorbidities:**

• Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise.

  4. **Cognitive Impairment:**

• Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
**Asses Health-Related Quality of Life:**	Baseline	Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)